An official website of the United States government Here’s how you know

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

In this section: Approved Blood Products

REBINYN

STN: 125611
Proper Name: Coagulation Factor IX (Recombinant), GlycoPEGylated
Tradename: REBINYN
Manufacturer: Novo Nordisk Inc.
Indication:

Is a recombinant DNA-derived coagulation Factor IX concentrate indicated for use in adults and children with hemophilia B for: (1) On-demand treatment and control of bleeding episodes; (2) Perioperative management of bleeding.

Product Information

Package Insert - REBINYN
Demographic Subgroup Information - REBINYN, Coagulation Factor IX (Recombinant), glycoPEGylated
Refer to Section 1.1 of the clinical reviewer memo for information about participation in the clinical trials and any analysis of demographic subgroup outcomes that is notable.

Supporting Documents

Top